Mucinex Childrens Mighty Chews Cough Nighttime Tablet, Chewable
NDC Package 72854-082-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mucinex Childrens Mighty Chews Cough Nighttime (dextromethorphan hbr and doxylamine succinate) tablets is mucinex Children's Mighty Chews Cough Daytime+Mucinex Children's Mighty Chews Cough Nighttime::■ take every 4 hours or as directed by a doctor ■ chew thoroughly before swallowing adults and children 12 years of age and over 2 chewable tablets every 4 hours, not to exceed 12 chewable tablets in any 24-hour period children 6 to under 12 years of age 1 chewable tablet every 4 hours, not to exceed 6 chewable tablets in any 24-hour period children under 6 years of agedo not use. This formulation utilizes a tablet, chewable delivery system. Marketed by Reckitt Benckiser Llc, this product is identified by NDC 72854-082 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
72854-082-16
Package Description
16 TABLET, CHEWABLE in 1 BOTTLE
Product Code
72854-082
11-Digit Billing Format
72854008216
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
16 EA
RxNorm Crosswalk
  • RxCUI: 2683423 - dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Chewable Tablet
  • RxCUI: 2683423 - dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Chewable Tablet
  • RxCUI: 2683424 - dextromethorphan hydrobromide 10 MG Chewable Tablet
  • RxCUI: 2683424 - dextromethorphan HBr 10 MG Chewable Tablet
  • RxCUI: 2683425 - {1 (dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Chewable Tablet) / 1 (dextromethorphan hydrobromide 10 MG Chewable Tablet) } Pack

Clinical Specifications

Proprietary Name
Mucinex Childrens Mighty Chews Cough Nighttime
Non-Proprietary Name
Dextromethorphan Hbr And Doxylamine Succinate
Substance Name
Dextromethorphan Hydrobromide; Doxylamine Succinate
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Mucinex Children's Mighty Chews Cough Daytime+Mucinex Children's Mighty Chews Cough Nighttime::■ take every 4 hours or as directed by a doctor ■ chew thoroughly before swallowing adults and children 12 years of age and over 2 chewable tablets every 4 hours, not to exceed 12 chewable tablets in any 24-hour period children 6 to under 12 years of age 1 chewable tablet every 4 hours, not to exceed 6 chewable tablets in any 24-hour period children under 6 years of agedo not use

Regulatory & Marketing

Labeler Name
Reckitt Benckiser Llc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-03-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72854-082-16 identifies a specific commercial package of 16 tablet, chewable in 1 bottle of Mucinex Childrens Mighty Chews Cough Nighttime, a human over the counter drug labeled by Reckitt Benckiser Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 16 billable units per package. This tablet, chewable is formulated for oral use and contains dextromethorphan hydrobromide; doxylamine succinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reckitt Benckiser Llc on June 03, 2024. The current certification is valid through December 31, 2027.

How is this Reckitt Benckiser Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72854008216. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 16 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72854-082-16
11-Digit CMS (5-4-2)
72854-0082-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.